levetiracetam 750 mg

1 INDICATIONS AND USAGE Levetiracetam extended-release tablets are indicated for the treatment of partial-onset seizures in patients 12 years of age and older. Levetiracetam is indicated for the treatment of partial-onset seizures in patients 12 years of age and older ( 1 )

ScieGen Pharmaceuticals, Inc

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] off label use` `[3] seizure` `[4] diarrhoea` `[5] fatigue` `[6] nausea` `[7] pyrexia` `[8] drug interaction` `[9] product use in unapproved indication` `[10] condition aggravated`

2 years ago

OVAL WHITE SG 190

2 years ago

SG 190 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied

LEVETIRACETAM extended-release tablets, USP 500 mg are white, oval-shaped, film-coated tablets, debossed with "SG" on one side and "189" on other side. They are supplied in white HDPE bottles containing 30 tablets (NDC 50228-189-30), 60 tablets (NDC 50228-189-60), and 500 tablets (NDC 50228-189-05).

LEVETIRACETAM extended-release tablets, USP 750 mg are white, oval-shaped, film-coated tablets, debossed with "SG" on one side and "190 on other side. They are supplied in white HDPE bottles containing 30 tablets (NDC 50228-190-30), 60 tablets (NDC 50228-190-60), and 500 tablets (NDC 50228-190-05). 16.2 Storage Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

More pills like OVAL SG 190

Related Pills

levetiracetam 500 mg

ScieGen Pharmaceuticals, Inc

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site